Cover Image
市場調查報告書

代謝體學市場:各產品與服務,用途,適應症 - 全球機會分析及產業預測

Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application, and Indication - Global Opportunity Analysis and Industry Forecast, 2017-2023

出版商 Allied Market Research 商品編碼 563258
出版日期 內容資訊 英文 165 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
代謝體學市場:各產品與服務,用途,適應症 - 全球機會分析及產業預測 Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application, and Indication - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日期: 2017年09月01日 內容資訊: 英文 165 Pages
簡介

本報告提供全球代謝體學市場相關調查,彙整市場各產品與服務,各用途,適應症,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 主要企業的定位
  • 波特五力分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 產品與服務別市場

  • 概要
  • 代謝體學設備
  • 生物資訊學工具及服務

第5章 各用途市場

  • 概要
  • 生物標記藥物研發
  • 藥物研發
  • 毒性實驗
  • 營養基因學
  • 功能基因學
  • 個人化醫療
  • 其他

第6章 各適應症市場

  • 概要
  • 癌症
  • 心血管疾病
  • 神經疾病
  • 代謝先天異常
  • 其他

第7章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第8章 企業簡介

目錄
Product Code: LI 17525

Metabolomics is an emerging field of science that performs systematic quantification and classification of metabolites in a biological system by using sophisticated analytical technologies. The analytical techniques used include spectroscopy, chromatography, and multivariate analysis. The global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023.

The global metabolomics market is driven by continues technological advancements in medical devices and adoption of metabolomics in precision medicine. Moreover, increased private & government funding for metabolomics R&D activities is expected to propel the market growth during the forecast period. However, high cost of analytical equipment & maintenance and lack of effective data management for metabolomics profiling are expected to hamper the market growth.

The global metabolomics market is segmented based on product & service, application, indication, and geography. Based on the product & service, it is categorized into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further divided into separation techniques and detection techniques. The separation techniques segment is further classified into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further categorized into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. The metabolomics bioinformatics tools & services segment is further divided into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Based on indication, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS:

  • The study provides an in-depth analysis of the global metabolomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product & service assists in understanding the key trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS:

By Product & Service

  • Metabolomics Instruments
  • Separation Techniques
  • High-performance Liquid Chromatography
  • Gas Chromatography
  • Ultra-performance Liquid Chromatography
  • Capillary Electrophoresis.
  • Detection Techniques
  • Mass Spectrometry
  • Nuclear Magnetic Resonance Spectroscopy
  • Surface-based Mass Analysis
  • Metabolomics Bioinformatics Tools & Services
  • Bioinformatics Tools
  • Databases and Bioinformatics Services

By Application

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Others

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

By Geography

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • The Netherlands
  • Norway
  • Russia
  • Sweden
  • Switzerland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • New Zealand
  • Taiwan
  • Thailand
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Chile
  • Columbia
  • Egypt
  • Iran
  • Israel
  • Turkey
  • Venezuela
  • Rest of LAMEA

KEY PLAYERS PROFILED:

  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Leco Corporation
  • Metabolon, Inc.
  • Human Metabolome Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • Thermo Fisher Scientific Inc.

The other players operating in the mass spectrometry market include (companies not profiled in the report):

  • Kore Technologies, Ltd.
  • Dani Instruments S.P.A.
  • Perkinelmer, Inc.
  • Evans Analytical Group LLC.

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
  • 3.3. TOP PLAYER POSITIONING
  • 3.4. PORTERS FIVE FORCES ANALYSIS
  • 3.5. MARKET DYNAMICS
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4 GLOBAL METABOLOMICS MARKET, BY PRODUCT & SERVICE

  • 4.1. OVERVIEW
    • 4.1.1. Market size & forecast
  • 4.2. METABOLOMICS INSTRUMENTS
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size & forecast
    • 4.2.4. Separation tools
      • 4.2.4.1. High-Performance Liquid Chromatography
      • 4.2.4.1.1. Market size & forecast
      • 4.2.4.2. Gas Chromatography
      • 4.2.4.2.1. Market size & forecast
      • 4.2.4.3. Ultra-Performance Liquid Chromatography
      • 4.2.4.3.1. Market size & forecast
      • 4.2.4.4. Capillary Electrophoresis
      • 4.2.4.4.1. Market size & forecast
    • 4.2.5. detection tools
      • 4.2.5.1. Mass Spectrometry
      • 4.2.5.1.1. Market size & forecast
      • 4.2.5.2. Nuclear Magnetic Resonance Spectroscopy
      • 4.2.5.2.1. Market size & forecast
      • 4.2.5.3. Surface-Based Mass Analysis
      • 4.2.5.3.1. Market size & forecast
  • 4.3. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size & forecast
    • 4.3.4. Bioinformatics Tools
      • 4.3.4.1. Market size & forecast
    • 4.3.5. Databases and Bioinformatics Services
      • 4.3.5.1. Market size & forecast

CHAPTER 5 GLOBAL METABOLOMICS MARKET, BY APPLICATION

  • 5.1. OVERVIEW
    • 5.1.1. Market size & forecast
  • 5.2. BIOMARKER DISCOVERY
    • 5.2.1. Market size & forecast
  • 5.3. DRUG DISCOVERY
    • 5.3.1. Market size & forecast
  • 5.4. TOXICOLOGY TESTING
    • 5.4.1. Market size & forecast
  • 5.5. NUTRIGENOMICS
    • 5.5.1. Market size & forecast
  • 5.6. FUNCTIONAL GENOMICS
    • 5.6.1. Market size & forecast
  • 5.7. PERSONALIZED MEDICINE
    • 5.7.1. Market size & forecast
  • 5.8. OTHER APPLICATION
    • 5.8.1. Market size & forecast

CHAPTER 6 GLOBAL METABOLOMICS MARKET, BY INDICATION

  • 6.1. OVERVIEW
    • 6.1.1. Market size & forecast
  • 6.2. CANCER
    • 6.2.1. Market size & forecast
  • 6.3. CARDIOVASCULAR DISORDERS
    • 6.3.1. Market size & forecast
  • 6.4. NEUROLOGICAL DISORDERS
    • 6.4.1. Market size & forecast
  • 6.5. INBORN ERRORS OF METABOLISM
    • 6.5.1. Market size & forecast
  • 6.6. OTHER INDIACTIONS
    • 6.6.1. Market size & forecast

CHAPTER 7 GLOBAL METABOLOMICS MARKET, BY GEOGRAPHY

  • 7.1. OVERVIEW
  • 7.2. NORTH AMERICA
    • 7.2.1. Key market trends
    • 7.2.2. Key growth factors and opportunities
    • 7.2.3. Market size & forecast
    • 7.2.4. Market size & forecast
      • 7.2.4.1. U.S. market size and forecast
      • 7.2.4.2. Canada market size and forecast
      • 7.2.4.3. Mexico market size and forecast
  • 7.3. EUROPE
    • 7.3.1. Key market trends
    • 7.3.2. Key growth factors and opportunities
    • 7.3.3. Market size & forecast
    • 7.3.4. Market size & forecast
      • 7.3.4.1. Germany market size and forecast
      • 7.3.4.2. France market size and forecast
      • 7.3.4.3. UK market size and forecast
      • 7.3.4.4. Italy market size and forecast
      • 7.3.4.5. Spain market size and forecast
      • 7.3.4.6. Rest of Europe market size and forecast
  • 7.4. ASIA-PACIFIC
    • 7.4.1. Key market trends
    • 7.4.2. Key growth factors and opportunities
    • 7.4.3. Market size & forecast
    • 7.4.4. Market size & forecast
      • 7.4.4.1. Japan market size and forecast
      • 7.4.4.2. China market size and forecast
      • 7.4.4.3. Australia market size and forecast
      • 7.4.4.4. India market size and forecast
      • 7.4.4.5. South Korea market size and forecast
      • 7.4.4.6. Taiwan market size and forecast
      • 7.4.4.7. Rest of Asia-Pacific market size and forecast
  • 7.5. LAMEA
    • 7.5.1. Key market trends
    • 7.5.2. Key growth factors and opportunities
    • 7.5.3. Market size & forecast
    • 7.5.4. Market size & forecast
      • 7.5.4.1. Brazil market size and forecast
      • 7.5.4.2. Turkey market size and forecast
      • 7.5.4.3. Saudi Arabia market size and forecast
      • 7.5.4.4. South Africa market size and forecast
      • 7.5.4.5. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

  • 8.1. AGILENT TECHNOLOGIES, INC.
    • 8.1.1. Operating business segments
    • 8.1.2. Business performance
  • 8.2. DANAHER CORPORATION
    • 8.2.1. Operating business segments
    • 8.2.2. Business performance
    • 8.2.3. Key strategic moves and developments
  • 8.3. BIOCRATES LIFE SCIENCES AG
    • 8.3.1. Operating business segments
    • 8.3.2. Business performance
    • 8.3.3. Key strategic moves and developments
  • 8.4. BRUKER CORPORATION
    • 8.4.1. Operating business segments
    • 8.4.2. Business performance
    • 8.4.3. Key strategic moves and developments
  • 8.5. LECO CORPORATION
    • 8.5.1. Operating business segments
    • 8.5.2. Business performance
    • 8.5.3. Key strategic moves and developments
  • 8.6. METABOLON, INC.
    • 8.6.1. Operating business segments
    • 8.6.2. Business performance
    • 8.6.3. Key strategic moves and developments
  • 8.7. HUMAN METABOLOME TECHNOLOGIES, INC.
    • 8.7.1. Operating business segments
    • 8.7.2. Business performance
    • 8.7.3. Key strategic moves and developments
  • 8.8. BIO-RAD LABORATORIES, INC.
    • 8.8.1. Operating business segments
    • 8.8.2. Business performance
    • 8.8.3. Key strategic moves and developments
  • 8.9. SHIMADZU CORPORATION
    • 8.9.1. Operating business segments
    • 8.9.2. Business performance
    • 8.9.3. Key strategic moves and developments
  • 8.10. WATERS CORPORATION
    • 8.10.1. Operating business segments
    • 8.10.2. Business performance
    • 8.10.3. Key strategic moves and developments
Back to Top